Provided by Tiger Trade Technology Pte. Ltd.

Solventum

64.03
-1.6600-2.53%
Post-market: 64.030.00000.00%19:54 EDT
Volume:1.68M
Turnover:107.55M
Market Cap:11.11B
PE:7.21
High:64.87
Open:64.00
Low:62.80
Close:65.69
52wk High:88.20
52wk Low:60.70
Shares:173.45M
Float Shares:147.51M
Volume Ratio:1.08
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.88
EPS(LYR):8.88
ROE:38.86%
ROA:2.94%
PB:2.20
PE(LYR):7.21

Loading ...

Solventum Corp. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Nov 26, 2025

Solventum to Join Piper Sandler Healthcare Conference

Reuters
·
Nov 26, 2025

Solventum on Track for Record High Close -- Data Talk

Dow Jones
·
Nov 25, 2025

Weekly Winners | Regeneron Surges 9%; Alphabet and Ross Stores Jump 8%; Medtronic Gains 6%

Tiger Newspress
·
Nov 23, 2025

Strategic Acquisition and Capital Management Propel Solventum Corporation’s Growth Potential

TIPRANKS
·
Nov 21, 2025

Solventum Corp. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Nov 21, 2025

BRIEF-Solventum Announces $1 Billion Share Repurchase Program

Reuters
·
Nov 20, 2025

Solventum to Acquire Acera Surgical for Up to $850 Million

Reuters
·
Nov 20, 2025

Solventum Announces Agreement to Acquire Acera Surgical

THOMSON REUTERS
·
Nov 20, 2025

Solventum Corp - Proposed Deal for $725 Mln

THOMSON REUTERS
·
Nov 20, 2025

Solventum Corp - to Finance Deal With Cash on Hand

THOMSON REUTERS
·
Nov 20, 2025

Solventum Corp - Deal Expected to Be Slightly Dilutive to Adj EPS in 2026 & Accretive From 2027

THOMSON REUTERS
·
Nov 20, 2025

Solventum Q3 Adjusted EPS USD 1.5 Vs. IBES Estimate USD 1.42

Reuters
·
Nov 20, 2025

Solventum Corporation Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Heather Knight

Reuters
·
Nov 19, 2025

Solventum Reports Q3 Sales of $2.1 Billion

Reuters
·
Nov 14, 2025

Binance Spot has added the SOLV/USDC, USD1/USDC, and WLFI/USD1 trading pairs

Blockbeats
·
Nov 12, 2025

Solventum Corp. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Nov 12, 2025

Solventum Is Maintained at Neutral by UBS

Dow Jones
·
Nov 11, 2025

UBS Adjusts Price Target on Solventum to $79 From $77, Maintains Neutral Rating

MT Newswires Live
·
Nov 10, 2025

Solventum price target raised to $79 from $77 at UBS

TIPRANKS
·
Nov 10, 2025